Carlos V Paya Standard Biotools Inc. (LAB) insider trading activity

LAB Quotes by TradingView

Carlos V Paya is Director of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 126,844 shares of LAB, which is worth approximately $246,077. The most recent transaction as insider was on Jun 14, 2023, when has been sold 26,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 127K
0% 3M change
0% 12M change
Total Value Held $246,077

Carlos V Paya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
BUY
Grant, award, or other acquisition
-
26,376 Added 17.21%
126,844 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
30,914 Added 23.53%
100,468 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
10,342 Added 12.94%
69,554 Common Stock
Mar 23 2021
BUY
Exercise of conversion of derivative security
-
2,500 Added 4.05%
59,212 Common Stock

Also insider at

PCVX
Vaxcyte, Inc. Healthcare
Director
MNKPF
Mallinckrodt plc Healthcare
Director
CVP

Carlos V Paya

Director
San Carlos, CA

Track Institutional and Insider Activities on LAB

Follow STANDARD BIOTOOLS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

News

Receive news related to STANDARD BIOTOOLS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LAB